ImmuLogic
Executive Summary
Files IND for Allervax Ragweed allergy therapeutic, company announces Dec. 8. The Waltham, Mass. company's first product, Allervax Cat, is in Phase II; reported results are being forecast for the end of the first quarter of 1994.